Services
-
Phase I/IIa
Over 35 years safe and compliant track record in Phase I/IIa project delivery to the pharmaceutical and biotechnology industries.
-
Bioequivalence Services
As a major global player in Clinical Research and Bioanalysis, we provide a wide range of services for bioequivalence studies to the pharmaceutical, and biotechnology industries.
-
505(b)(2)-Generic Hybrid
Development of new or different formulations for known drugs is now a very interesting asset in R&D and clinical research. As a global leader in scientific, clinical and bioanalysis research and through key alliances critical to this sector, our team of experts can help you design and conduct your study successfully.
-
Bioanalysis
Our Bioanalytical Services Department strives for scientific excellence, uncompromised quality and unbeatable timelines to meet and exceed client needs. Our wealth of bioanalytic experience has been gained across different matrices, including plasma, serum, whole blood, urine, cerebro-spinal fluid, tissues and faeces.
-
Central Lab
Analytical services are an integral part of the drug and medicines development process. Simbec’s GLP/GCP compliant Central Laboratory Services provide essential supporting analyses for Phase I-IV trials; these services are designed exclusively for the Pharmaceutical industry.
